In the News | Charles River
   
 
 
   
   

Guarding the Heart
The best time to discover that a drug has cardiovascular liabilities is early in the drug research process. Assays that identify toxicities in preclinical phases can help.
Drug Discovery & Development – June 1, 2009

The cardiovascular system is a vital part of the human body. It is responsible for important tasks such as supplying nutrients, removing waste, distributing hormones and regulatory substances, maintaining osmotic balance and homeostasis. It is also one of the more delicate systems in the human body and can be impacted by both cardiovascular and non-cardiovascular drugs. As a result, drug development programs are complex and often require multidisciplinary research when assessing potential cardiovascular toxicity...Read the full article.

   
Discover the full range of Charles River Products and Services
The Source

For more information, contact us at:

1.877.CRIVER.1 (1.877.274.8371)
askcharlesriver@crl.com

view all

News & Events

view all
Jan 20 - Access Preclinical Study Data with...
Jan 18 - Elemental Analysis by ICP-OES Now ...
Feb 17-Feb 18 - Aichi, Japan - Japan Society of Experimental Diabetes and Obesity (JSED...
Feb 08-Feb 10 - Brussels, Belgium - 6th Charles River European Short Course on Laborato...
view all
Scientist I Wilmington, MA
Manager International Tax Wilmington, MA

Charles River Laboratories, Inc.